St. Jude Children’s Research Hospital scientists have developed a computational tool to identify alterations that drive tumor formation in 98% of the genome. Gene coding regions constitute 2% of the human genome.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
